Phase II Study of Vinorelbine Plus Trastuzumab in HER2 Overexpressing Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

PURPOSE: The role of first-line trastuzumab-based therapy has been firmly established in patients with human epidermal growth factor receptor-2 (HER2) positive metastatic breast cancer. In this trial, we evaluated the efficacy and safety of a vinorelbine and trastuzumab combination chemotherapy in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yu Rim, Huh, Seok Jae, Lee, Dong Hyun, Yoon, Hyun Hwa, Seol, Young-Mi, Choi, Young-Jin, Kwon, Kyung A, Lee, Suee, Oh, Sung Yong, Kim, Sung-Hyun, Kim, Hyo-Jin, Kwon, Hyuk-Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148545/
https://www.ncbi.nlm.nih.gov/pubmed/21847410
http://dx.doi.org/10.4048/jbc.2011.14.2.140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148545/
https://www.ncbi.nlm.nih.gov/pubmed/21847410
http://dx.doi.org/10.4048/jbc.2011.14.2.140

Ejemplares similares